Single species accepted per EU gene therapy guidelines; LPL-deficient mice and cats used as disease models
“The use of a single species for toxicity evaluation is in accordance with the guideline for gene therapy medicinal products EMEA/CHMP/GTWP/587488/2007 and the guideline on the non-clinical studies required before first clinical use of gene therapy medicinal products (EMEA/CHMP/GTWP/12459/2006).”
No surrogate; clinical vector AMT-011 (baculovirus) and earlier plasmid-derived AMT-010 tested in mice
“Studies were conducted with AMT-010 (plasmid derived) and several different batches of AMT-011 (baculovirus derived) and doses ranged from 1x1011 – 1x1013 gc/kg.”